Skip to main content
Top
Published in: BioPsychoSocial Medicine 1/2018

Open Access 01-12-2018 | Research

Association between chronological depressive changes and physical symptoms in postoperative pancreatic cancer patients

Authors: Naoko Sato, Yoshimi Hasegawa, Asami Saito, Fuyuhiko Motoi, Kyohei Ariake, Yu Katayose, Kei Nakagawa, Kei Kawaguchi, Shin Fukudo, Michiaki Unno, Fumiko Sato

Published in: BioPsychoSocial Medicine | Issue 1/2018

Login to get access

Abstract

Background

Pancreatic cancer (PC) has poorer prognosis and higher surgical invasiveness than many other cancers, with associated psychiatric symptoms including depression and anxiety. Perioperative depression has not been investigated in PC patients regarding surgical stress and relevant interventions.

Methods

We evaluated chronological depressive changes and subjective physical symptoms in surgically treated PC patients preoperatively and at 3 and 6 months postoperatively.
Enrolled patients undergoing pancreatic tumor surgery completed questionnaires based on the Self-Rating Depression Scale (SDS) and Functional Assessment of Cancer Therapy for Patients with Hepatobiliary Cancer (FACT-Hep) preoperatively, and at 3 and 6 months postoperatively. Responses were analyzed with JMP® Pro using one-way and two-way ANOVA, Spearman’s rank correlation coefficient, and multiple regression analysis.

Results

Malignancy was diagnosed in 73 of 101 patients postoperatively; SDS score was significantly higher in these patients than in those with benign tumors at all timepoints: malignant/benign, 41.8/37.9 preoperatively (p = 0.004); 43.5/37.8 3 months postoperatively (p = 0.006); and 42.9/37.7 6 months postoperatively (p = 0.020). SDS scores were significantly higher in patients < 65 years old with malignancy at 3 months than at 6 months postoperatively (44.6/42.5, p = 0.046) and in patients with malignancy who underwent pancreaticoduodenectomy at 3 months postoperatively than preoperatively (43.4/41.1; p = 0.028). SDS scores moderately correlated with 8 physical symptom-related FACT-Hep items 3 months postoperatively (p < 0.05), showing low-to-moderate correlation with 16 physical symptom-related FACT-Hep items at 6 months postoperatively (p < 0.05). Multiple regression analysis of FACT-Hep symptoms significantly correlated with SDS scores revealed the following significant variables: “lack of energy” (p < 0.000) and “pain” (p = 0.018) preoperatively (R2 = 0.43); “able to perform usual activities” (p = 0.031) and “lack of energy” (p < 0.000) at 3 months postoperatively (R2 = 0.51); and “stomach swelling or cramps” (p = 0.034) and “bowel control” (p = 0.049) at 6 months postoperatively (R2 = 0.52).

Conclusions

PC patients experience persistently high levels of depression preoperatively through 6 months postoperatively, with associated subjective symptoms including pain and gastrointestinal symptoms.

Trial registration

UMIN Clinical Trials Registry 000009592, Registered 20 December 2012.
Literature
2.
go back to reference Doi R, Imamura M, Hosotani R, Imaizumi T, Hatori T, Takasaki K, et al. Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: final results of a randomized multi-institutional trial. Surg Today 2008;38(11):1021–1028. doi: https://doi.org/10.1007/s00595-007-3745-8. PubMed PMID: 18958561.CrossRef Doi R, Imamura M, Hosotani R, Imaizumi T, Hatori T, Takasaki K, et al. Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: final results of a randomized multi-institutional trial. Surg Today 2008;38(11):1021–1028. doi: https://​doi.​org/​10.​1007/​s00595-007-3745-8. PubMed PMID: 18958561.CrossRef
3.
7.
go back to reference Wang H, Chen T, Wang H, Song Y, Li X, Wang J. A systematic review of the physiological and operative severity score for the enUmeration of mortality and morbidity and its Portsmouth modification as predictors of post-operative morbidity and mortality in patients undergoing pancreatic surgery. Am J Surg 2013;205(4):466–472. doi: https://doi.org/10.1016/j.amjsurg.2012.06.011. PubMed PMID: 23395580.CrossRef Wang H, Chen T, Wang H, Song Y, Li X, Wang J. A systematic review of the physiological and operative severity score for the enUmeration of mortality and morbidity and its Portsmouth modification as predictors of post-operative morbidity and mortality in patients undergoing pancreatic surgery. Am J Surg 2013;205(4):466–472. doi: https://​doi.​org/​10.​1016/​j.​amjsurg.​2012.​06.​011. PubMed PMID: 23395580.CrossRef
9.
go back to reference Jia L, Jiang SM, Shang YY, Huang YX, Li YJ, Xie DR, et al. Investigation of the incidence of pancreatic cancer-related depression and its relationship with the quality of life of patients. Digestion 2010;82(1):4–9. Epub 2010/02/11. doi: https://doi.org/10.1159/000253864. PubMed PMID: 20145402.CrossRef Jia L, Jiang SM, Shang YY, Huang YX, Li YJ, Xie DR, et al. Investigation of the incidence of pancreatic cancer-related depression and its relationship with the quality of life of patients. Digestion 2010;82(1):4–9. Epub 2010/02/11. doi: https://​doi.​org/​10.​1159/​000253864. PubMed PMID: 20145402.CrossRef
11.
go back to reference Kim GM, Kim SJ, Song SK, Kim HR, Kang BD, Noh SH, et al. Prevalence and prognostic implications of psychological distress in patients with gastric cancer. BMC cancer. 2017;17(1):283. Epub 2017/04/22. doi: https://doi.org/10.1186/s12885-017-3260-2. PubMed PMID: 28427439; PubMed Central PMCID: PMCPMC5399416. Kim GM, Kim SJ, Song SK, Kim HR, Kang BD, Noh SH, et al. Prevalence and prognostic implications of psychological distress in patients with gastric cancer. BMC cancer. 2017;17(1):283. Epub 2017/04/22. doi: https://​doi.​org/​10.​1186/​s12885-017-3260-2. PubMed PMID: 28427439; PubMed Central PMCID: PMCPMC5399416.
15.
go back to reference Braun DP, Gupta D, Staren ED. Longitudinal health-related quality of life assessment implications for prognosis in stage IV pancreatic Cancer. Pancreas. 2012;00(00):1–6. Braun DP, Gupta D, Staren ED. Longitudinal health-related quality of life assessment implications for prognosis in stage IV pancreatic Cancer. Pancreas. 2012;00(00):1–6.
18.
go back to reference Eaton AA, Gonen M, Karanicolas P, Jarnagin WR, D'Angelica MI, DeMatteo R, et al. Health-Related Quality of Life After Pancreatectomy: Results From a Randomized Controlled Trial. Annals of surgical oncology. 2016;23(7):2137–45. Epub 2016/01/21. doi: https://doi.org/10.1245/s10434-015-5077-z. PubMed PMID: 26786091; PubMed Central PMCID: PMCPMC4891251.CrossRef Eaton AA, Gonen M, Karanicolas P, Jarnagin WR, D'Angelica MI, DeMatteo R, et al. Health-Related Quality of Life After Pancreatectomy: Results From a Randomized Controlled Trial. Annals of surgical oncology. 2016;23(7):2137–45. Epub 2016/01/21. doi: https://​doi.​org/​10.​1245/​s10434-015-5077-z. PubMed PMID: 26786091; PubMed Central PMCID: PMCPMC4891251.CrossRef
19.
go back to reference Sugimoto H, Kawashima H, Ohno E, Hayashi D, Kuwahara T, Morishima T, et al. The prognostic factors and trajectory of HRQOL in patients with pancreatic cancer who received psychiatric intervention. J Gastroenterol Hepatol 2016;31(3):685–690. Epub 2015/09/29. doi: https://doi.org/10.1111/jgh.13172. PubMed PMID: 26412310.CrossRef Sugimoto H, Kawashima H, Ohno E, Hayashi D, Kuwahara T, Morishima T, et al. The prognostic factors and trajectory of HRQOL in patients with pancreatic cancer who received psychiatric intervention. J Gastroenterol Hepatol 2016;31(3):685–690. Epub 2015/09/29. doi: https://​doi.​org/​10.​1111/​jgh.​13172. PubMed PMID: 26412310.CrossRef
20.
go back to reference Jimenez-Fonseca P, Carmona-Bayonas A, Martin-Perez E, Crespo G, Serrano R, Llanos M, et al. Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors. Cancer Metastasis Rev 2015;34(3):381–400. Epub 2015/08/08. doi: https://doi.org/10.1007/s10555-015-9573-1. PubMed PMID: 26245646.CrossRef Jimenez-Fonseca P, Carmona-Bayonas A, Martin-Perez E, Crespo G, Serrano R, Llanos M, et al. Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors. Cancer Metastasis Rev 2015;34(3):381–400. Epub 2015/08/08. doi: https://​doi.​org/​10.​1007/​s10555-015-9573-1. PubMed PMID: 26245646.CrossRef
21.
go back to reference Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63–70. PubMed PMID: 14221692.CrossRef Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63–70. PubMed PMID: 14221692.CrossRef
22.
go back to reference Fukuda K, Kobayashi S. A study on a self-rating depression scale. Seishin Shinkeigaku Zasshi. 1973;75:673–9.PubMed Fukuda K, Kobayashi S. A study on a self-rating depression scale. Seishin Shinkeigaku Zasshi. 1973;75:673–9.PubMed
24.
go back to reference Sharpley CF, Christie DR, Bitsika V, Miller BJ. Trajectories of total depression and depressive symptoms in prostate cancer patients receiving six months of hormone therapy. Psycho-Oncology 2017;26(1):60–66. Epub 2016/02/10. doi: https://doi.org/10.1002/pon.4100. PubMed PMID: 26857160.CrossRef Sharpley CF, Christie DR, Bitsika V, Miller BJ. Trajectories of total depression and depressive symptoms in prostate cancer patients receiving six months of hormone therapy. Psycho-Oncology 2017;26(1):60–66. Epub 2016/02/10. doi: https://​doi.​org/​10.​1002/​pon.​4100. PubMed PMID: 26857160.CrossRef
25.
go back to reference Guo X, Xu J, Ying E, Yu Z, Sun T. Correlation between hormone receptor status and depressive symptoms in patients with metastatic breast cancer. Oncotarget. 2017;8(31):50774–50781. Epub 2017/09/09. doi: https://doi.org/10.18632/oncotarget.15037. PubMed PMID: 28881602; PubMed Central PMCID: PMCPMC5584203. Guo X, Xu J, Ying E, Yu Z, Sun T. Correlation between hormone receptor status and depressive symptoms in patients with metastatic breast cancer. Oncotarget. 2017;8(31):50774–50781. Epub 2017/09/09. doi: https://​doi.​org/​10.​18632/​oncotarget.​15037. PubMed PMID: 28881602; PubMed Central PMCID: PMCPMC5584203.
26.
go back to reference Chen J, Li W, Cui L, Qian Y, Zhu Y, Gu H, et al. Chemotherapeutic Response and Prognosis among Lung Cancer Patients with and without Depression. J Cancer. 2015;6(11):1121–1129. Epub 2015/10/31. doi: https://doi.org/10.7150/jca.11239. PubMed PMID: 26516360; PubMed Central PMCID: PMCPMC4615348.CrossRef Chen J, Li W, Cui L, Qian Y, Zhu Y, Gu H, et al. Chemotherapeutic Response and Prognosis among Lung Cancer Patients with and without Depression. J Cancer. 2015;6(11):1121–1129. Epub 2015/10/31. doi: https://​doi.​org/​10.​7150/​jca.​11239. PubMed PMID: 26516360; PubMed Central PMCID: PMCPMC4615348.CrossRef
27.
go back to reference Heffernan N, Cella D, Webster K, Odom L, Martone M, Passik S, et al. Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol 2002;20(9):2229–2239. Epub 2002/05/01. PubMed PMID: 11980994.CrossRef Heffernan N, Cella D, Webster K, Odom L, Martone M, Passik S, et al. Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol 2002;20(9):2229–2239. Epub 2002/05/01. PubMed PMID: 11980994.CrossRef
28.
go back to reference Yount S, Cella D, Webster K, Heffernan N, Chang C, Odom L, et al. Assessment of patient-reported clinical outcome in pancreatic and other hepatobiliary cancers: the FACT hepatobiliary symptom index. J Pain Symptom Manag 2002;24(1):32–44. Epub 2002/08/17. PubMed PMID: 12183093.CrossRef Yount S, Cella D, Webster K, Heffernan N, Chang C, Odom L, et al. Assessment of patient-reported clinical outcome in pancreatic and other hepatobiliary cancers: the FACT hepatobiliary symptom index. J Pain Symptom Manag 2002;24(1):32–44. Epub 2002/08/17. PubMed PMID: 12183093.CrossRef
29.
go back to reference Diaz-Frutos D, Baca-Garcia E, Garcia-Foncillas J, Lopez-Castroman J. Predictors of psychological distress in advanced cancer patients under palliative treatments. Eur J Cancer Care (Engl) 2016;25(4):608–615. Epub 2016/06/09. doi: https://doi.org/10.1111/ecc.12521. PubMed PMID: 27271213.CrossRef Diaz-Frutos D, Baca-Garcia E, Garcia-Foncillas J, Lopez-Castroman J. Predictors of psychological distress in advanced cancer patients under palliative treatments. Eur J Cancer Care (Engl) 2016;25(4):608–615. Epub 2016/06/09. doi: https://​doi.​org/​10.​1111/​ecc.​12521. PubMed PMID: 27271213.CrossRef
30.
go back to reference Zhu L, Ranchor AV, Helgeson VS, van der Lee M, Garssen B, Stewart RE, et al. Benefit finding trajectories in cancer patients receiving psychological care: predictors and relations to depressive and anxiety symptoms. Br J Health Psychol 2018;23(2):238–252. Epub 2017/11/16. doi: https://doi.org/10.1111/bjhp.12283. PubMed PMID: 29139593.CrossRef Zhu L, Ranchor AV, Helgeson VS, van der Lee M, Garssen B, Stewart RE, et al. Benefit finding trajectories in cancer patients receiving psychological care: predictors and relations to depressive and anxiety symptoms. Br J Health Psychol 2018;23(2):238–252. Epub 2017/11/16. doi: https://​doi.​org/​10.​1111/​bjhp.​12283. PubMed PMID: 29139593.CrossRef
33.
go back to reference Kobayashi G, Fujita N, Maguchi H, Tanno S, Mizuno N, Hanada K, et al. Natural history of branch duct intraductal papillary mucinous neoplasm with mural nodules: a Japan Pancreas Society multicenter study. Pancreas. 2014;43(4):532–8. doi: https://doi.org/10.1097/MPA.0000000000000080. PubMed PMID: 24717801; PubMed Central PMCID: PMCPMC4206346.CrossRef Kobayashi G, Fujita N, Maguchi H, Tanno S, Mizuno N, Hanada K, et al. Natural history of branch duct intraductal papillary mucinous neoplasm with mural nodules: a Japan Pancreas Society multicenter study. Pancreas. 2014;43(4):532–8. doi: https://​doi.​org/​10.​1097/​MPA.​0000000000000080​. PubMed PMID: 24717801; PubMed Central PMCID: PMCPMC4206346.CrossRef
34.
go back to reference Deckx L, van den Akker M, van Driel M, Bulens P, van Abbema D, Tjan-Heijnen V, et al. Loneliness in patients with cancer: the first year after cancer diagnosis. Psycho-Oncology 2015;24(11):1521–1528. Epub 2015/04/29. doi: https://doi.org/10.1002/pon.3818. PubMed PMID: 25914244.CrossRef Deckx L, van den Akker M, van Driel M, Bulens P, van Abbema D, Tjan-Heijnen V, et al. Loneliness in patients with cancer: the first year after cancer diagnosis. Psycho-Oncology 2015;24(11):1521–1528. Epub 2015/04/29. doi: https://​doi.​org/​10.​1002/​pon.​3818. PubMed PMID: 25914244.CrossRef
35.
go back to reference Muramatsu K, Matsuda S, Hayashida K, Kubo T, Fujino Y, Fujimori K, et al. Do the Japanese Cancer patients receive an appropriate psychiatric support at the acute care hospitals? —an evaluation trial by DPC based data—. Asian Pacific J Dis Manage. 2011;5(1):13–7.CrossRef Muramatsu K, Matsuda S, Hayashida K, Kubo T, Fujino Y, Fujimori K, et al. Do the Japanese Cancer patients receive an appropriate psychiatric support at the acute care hospitals? —an evaluation trial by DPC based data—. Asian Pacific J Dis Manage. 2011;5(1):13–7.CrossRef
36.
go back to reference Diener MK, Fitzmaurice C, Schwarzer G, Seiler CM, Antes G, Knaebel HP, et al. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev 2011;(5):CD006053. doi: https://doi.org/10.1002/14651858.CD006053.pub4. PubMed PMID: 21563148. Diener MK, Fitzmaurice C, Schwarzer G, Seiler CM, Antes G, Knaebel HP, et al. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev 2011;(5):CD006053. doi: https://​doi.​org/​10.​1002/​14651858.​CD006053.​pub4. PubMed PMID: 21563148.
37.
go back to reference Karanicolas PJ, Davies E, Kunz R, Briel M, Koka HP, Payne DM, et al. The pylorus: take it or leave it? Systematic review and meta-analysis of pylorus-preserving versus standard whipple pancreaticoduodenectomy for pancreatic or periampullary cancer. Ann Surg Oncol 2007;14(6):1825–1834. doi: https://doi.org/10.1245/s10434-006-9330-3. PubMed PMID: 17342566.CrossRef Karanicolas PJ, Davies E, Kunz R, Briel M, Koka HP, Payne DM, et al. The pylorus: take it or leave it? Systematic review and meta-analysis of pylorus-preserving versus standard whipple pancreaticoduodenectomy for pancreatic or periampullary cancer. Ann Surg Oncol 2007;14(6):1825–1834. doi: https://​doi.​org/​10.​1245/​s10434-006-9330-3. PubMed PMID: 17342566.CrossRef
38.
go back to reference Kawai M, Tani M, Hirono S, Miyazawa M, Shimizu A, Uchiyama K, et al. Pylorus ring resection reduces delayed gastric emptying in patients undergoing pancreatoduodenectomy: a prospective, randomized, controlled trial of pylorus-resecting versus pylorus-preserving pancreatoduodenectomy. Ann Surg 2011;253(3):495–501. doi: https://doi.org/10.1097/SLA.0b013e31820d98f1. PubMed PMID: 21248633.CrossRef Kawai M, Tani M, Hirono S, Miyazawa M, Shimizu A, Uchiyama K, et al. Pylorus ring resection reduces delayed gastric emptying in patients undergoing pancreatoduodenectomy: a prospective, randomized, controlled trial of pylorus-resecting versus pylorus-preserving pancreatoduodenectomy. Ann Surg 2011;253(3):495–501. doi: https://​doi.​org/​10.​1097/​SLA.​0b013e31820d98f1​. PubMed PMID: 21248633.CrossRef
39.
go back to reference Matsumoto I, Shinzeki M, Asari S, Goto T, Shirakawa S, Ajiki T, et al. A prospective randomized comparison between pylorus- and subtotal stomach-preserving pancreatoduodenectomy on postoperative delayed gastric emptying occurrence and long-term nutritional status. J Surg Oncol 2014;109(7):690–696. doi: https://doi.org/10.1002/jso.23566. PubMed PMID: 24619624.CrossRef Matsumoto I, Shinzeki M, Asari S, Goto T, Shirakawa S, Ajiki T, et al. A prospective randomized comparison between pylorus- and subtotal stomach-preserving pancreatoduodenectomy on postoperative delayed gastric emptying occurrence and long-term nutritional status. J Surg Oncol 2014;109(7):690–696. doi: https://​doi.​org/​10.​1002/​jso.​23566. PubMed PMID: 24619624.CrossRef
41.
go back to reference Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, et al. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet 2016;388(10041):248–257. doi: https://doi.org/10.1016/S0140-6736(16)30583-9. PubMed PMID: 27265347.CrossRef Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, et al. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet 2016;388(10041):248–257. doi: https://​doi.​org/​10.​1016/​S0140-6736(16)30583-9. PubMed PMID: 27265347.CrossRef
42.
go back to reference Van Laethem JL, Hammel P, Mornex F, Azria D, Van Tienhoven G, Vergauwe P, et al. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. J Clin Oncol. 2010;28(29):4450–4456. Epub 2010/09/15. doi: https://doi.org/10.1200/jco.2010.30.3446. PubMed PMID: 20837948; PubMed Central PMCID: PMCPMC2988636.CrossRef Van Laethem JL, Hammel P, Mornex F, Azria D, Van Tienhoven G, Vergauwe P, et al. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. J Clin Oncol. 2010;28(29):4450–4456. Epub 2010/09/15. doi: https://​doi.​org/​10.​1200/​jco.​2010.​30.​3446. PubMed PMID: 20837948; PubMed Central PMCID: PMCPMC2988636.CrossRef
43.
go back to reference Cloyd JM, Tran Cao HS, Petzel MQ, Denbo JW, Parker NH, Nogueras-Gonzalez GM, et al. Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms. J Surg Oncol 2017;115(2):144–150. Epub 2016/11/20. doi: https://doi.org/10.1002/jso.24499. PubMed PMID: 27859270.CrossRef Cloyd JM, Tran Cao HS, Petzel MQ, Denbo JW, Parker NH, Nogueras-Gonzalez GM, et al. Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms. J Surg Oncol 2017;115(2):144–150. Epub 2016/11/20. doi: https://​doi.​org/​10.​1002/​jso.​24499. PubMed PMID: 27859270.CrossRef
47.
go back to reference Carney CP, Jones L, Woolson RF, Noyes R, Jr., Doebbeling BN. Relationship between depression and pancreatic cancer in the general population. Psychosom Med 2003;65(5):884–888. PubMed PMID: 14508036.CrossRef Carney CP, Jones L, Woolson RF, Noyes R, Jr., Doebbeling BN. Relationship between depression and pancreatic cancer in the general population. Psychosom Med 2003;65(5):884–888. PubMed PMID: 14508036.CrossRef
49.
go back to reference Patsou ED, Alexias GD, Anagnostopoulos FG, Karamouzis MV. Effects of physical activity on depressive symptoms during breast cancer survivorship: a meta-analysis of randomised control trials. ESMO open. 2017;2(5):e000271. Epub 2017/12/21. doi: https://doi.org/10.1136/esmoopen-2017-000271. PubMed PMID: 29259819; PubMed Central PMCID: PMCPMC5729305.CrossRef Patsou ED, Alexias GD, Anagnostopoulos FG, Karamouzis MV. Effects of physical activity on depressive symptoms during breast cancer survivorship: a meta-analysis of randomised control trials. ESMO open. 2017;2(5):e000271. Epub 2017/12/21. doi: https://​doi.​org/​10.​1136/​esmoopen-2017-000271. PubMed PMID: 29259819; PubMed Central PMCID: PMCPMC5729305.CrossRef
51.
go back to reference Tabrizi FM, Radfar M, Taei Z. Effects of supportive-expressive discussion groups on loneliness, hope and quality of life in breast cancer survivors: a randomized control trial. Psycho-Oncology 2016;25(9):1057–1063. Epub 2016/06/16. doi: https://doi.org/10.1002/pon.4169. PubMed PMID: 27302306.CrossRef Tabrizi FM, Radfar M, Taei Z. Effects of supportive-expressive discussion groups on loneliness, hope and quality of life in breast cancer survivors: a randomized control trial. Psycho-Oncology 2016;25(9):1057–1063. Epub 2016/06/16. doi: https://​doi.​org/​10.​1002/​pon.​4169. PubMed PMID: 27302306.CrossRef
52.
go back to reference Chen SF, Wang HH, Yang HY, Chung UL. Effect of Relaxation With Guided Imagery on The Physical and Psychological Symptoms of Breast Cancer Patients Undergoing Chemotherapy. Iranian Red Crescent Med J. 2015;17(11):e31277. Epub 2016/01/07. doi: https://doi.org/10.5812/ircmj.31277. PubMed PMID: 26734485; PubMed Central PMCID: PMCPMC4698327. Chen SF, Wang HH, Yang HY, Chung UL. Effect of Relaxation With Guided Imagery on The Physical and Psychological Symptoms of Breast Cancer Patients Undergoing Chemotherapy. Iranian Red Crescent Med J. 2015;17(11):e31277. Epub 2016/01/07. doi: https://​doi.​org/​10.​5812/​ircmj.​31277. PubMed PMID: 26734485; PubMed Central PMCID: PMCPMC4698327.
Metadata
Title
Association between chronological depressive changes and physical symptoms in postoperative pancreatic cancer patients
Authors
Naoko Sato
Yoshimi Hasegawa
Asami Saito
Fuyuhiko Motoi
Kyohei Ariake
Yu Katayose
Kei Nakagawa
Kei Kawaguchi
Shin Fukudo
Michiaki Unno
Fumiko Sato
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BioPsychoSocial Medicine / Issue 1/2018
Electronic ISSN: 1751-0759
DOI
https://doi.org/10.1186/s13030-018-0132-1

Other articles of this Issue 1/2018

BioPsychoSocial Medicine 1/2018 Go to the issue